AGX vs AME
Argan, Inc. vs Ametek — AI-powered side-by-side comparison
| Metric | AGX | AME |
|---|
| AI Score |
57
|
70
|
| Price |
$579.08
|
$256.07
|
| P/E Ratio |
49.74×
|
37.31×
|
| ROE |
29.8%
|
13.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
20.9%
|
36.6%
|
| Debt / Equity |
0.00×
|
0.21×
|
| Dividend Yield |
0.3%
|
0.5%
|
| RSI (14) |
46.6
|
67.3
|
| Beta |
0.612
|
0.99
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for AGX versus AME.
AME leads by 13 points.
AME scores 70/100 (Buy) versus AGX at 57/100 (Buy).
AGX Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 22.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- Bollinger bandwidth of 22.8% signals elevated volatility — Risk
AME Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.21) -- balance sheet can absorb a shock. The main limiting factor is p/e of 36.9 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- P/E of 36.9 is moderate-to-rich — Value
- Price-to-book of 4.4x prices in significant intangible value — Value
- Weekly RSI at 79 -- overbought on the larger timeframe too — Technical